Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Small cell lung cancer extensive stage: Which Medications Are Safest? (88 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

88 medications are used for Small cell lung cancer extensive stage, with 2,652 combined adverse event reports. The most reported drugs for Small cell lung cancer extensive stage are ATEZOLIZUMAB and ETOPOSIDE.

2,652
Total Reports
88
Drugs Used

All Medications for Small cell lung cancer extensive stage Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
ATEZOLIZUMAB Tecentriq Hybreza 1,398 8,520 15,094 25.3%
ETOPOSIDE Avopef 1,336 11,780 17,699 22.4%
CARBOPLATIN Carboplatin 1,265 12,544 35,869 14.9%
DURVALUMAB IMFINZI 660 5,088 5,968 29.7%
CISPLATIN CISplatin 128 8,387 17,469 17.7%
TARLATAMAB-DLLE IMDELLTRA (AMG757) 127 103 206 12.8%
IRINOTECAN Irinotecan Hydrochloride 98 4,530 10,384 16.2%
BEVACIZUMAB JOBEVNE 79 17,498 23,114 22.4%
LURBINECTEDIN ZEPZELCA 56 252 337 26.1%
NIVOLUMAB OPDIVO 41 23,086 36,530 26.3%
UNSPECIFIED INGREDIENT - 41 6,132 11,236 23.4%
PEMBROLIZUMAB KEYTRUDA 39 15,543 35,472 18.6%
TARLATAMAB - 33 49 52 33.8%
TISLELIZUMAB TEVIMBRA 31 114 2,586 2.3%
TIRAGOLUMAB - 30 101 424 18.2%
IPILIMUMAB YERVOY 28 8,043 17,031 22.0%
PACLITAXEL PACLITAXEL PACLITAXEL 20 12,030 31,638 15.6%
VINCRISTINE VinCRIStine Sulfate 20 14,548 26,911 20.1%
CATEQUENTINIB - 19 44 115 13.6%
CYCLOPHOSPHAMIDE Cyclophosphamide 18 25,330 45,054 19.7%

View all 88 drugs →

Most Reported Drugs for Small cell lung cancer extensive stage

#1 most reported
#2 most reported
#3 most reported